A short, 1-month treatment combining antiplatelet medication and aspirin followed by an aspirin-only regimen was as effective as a 6- to 12-month course of dual treatment at preventing death, myocardial infarction, stroke, bleeding or revascularization,according to late-breaking trial results presented Sunday at the American Heart Association Scientific Sessions 2020 virtual conference.